Evidence map›Paper›PMID 40304039›Full record

Trial reportJournal of cosmetic dermatology2025

Superficial Intradermal Injections of Cohesive Polydensified Matrix Hyaluronic Acid Fillers for the Improvement of Facial Pores and Skin Quality: A Split-Face Randomized Study.

Thanachat Rutnumnoi, Pasita Palakornkitti, Tanaporn Anuntrangsee, Tanat Yongpisarn, Nawara Sakpuwadol, Vasanop Vachiramon

Abstract readRandomized Controlled TrialComparative Study
In one paragraph

Trial report in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Thanachat RutnumnoiDivision of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Pasita PalakornkittiDivision of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Tanaporn AnuntrangseeDivision of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Tanat YongpisarnDivision of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Nawara SakpuwadolDivision of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Vasanop VachiramonDivision of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.ORCID https://orcid.org/0000-0002-7328-939X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVarious therapeutic options have been introduced for enlarged facial pores including low cross-linked hyaluronic acid (HA) fillers. Newer formulations of HA-based dermal fillers are continuously introduced into the market, but their effectiveness in reducing enlarged facial pores has not yet been determined.

objectivesTo compare the efficacy of HA-based dermal fillers (Cohesive Polydensified Matrix HA filler; CPM-HA20) versus CPM-HA20 with glycerol (CPM-HA20G) in terms of minimizing enlarged facial pores and skin quality improvement.

methodsThirty subjects with enlarged facial pores were enrolled in this randomized, double-blinded, split-face study. Participants were randomly assigned to be injected with 1 mL of CPM-HA20 filler on one side of their medial cheek and 1 mL of CPM-HA20G on the contralateral side for 3 sessions spaced 4 weeks apart. Pore volume was objectively measured by an Antera 3D. Skin biophysical properties were evaluated. Participant satisfaction and adverse events were recorded.

resultsTwenty-nine participants completed the study. Both treatment groups showed a reduction in the mean pore volume from the baseline through Week 32. The CPM-HA20G treated side showed a 24.2% higher reduction in mean pore volume from baseline compared to the CPM-HA20 treated side (p = 0.038). Both treatment groups showed improvement in skin hydration from baseline to Week 32. There was no significant difference in patient satisfaction between the CPM-HA20G and CPM-HA20 treated sides. Only mild adverse events such as pain, edema, and bruising were reported.

conclusionThree-monthly injections of CPM-HA20G and CPM-HA20 were effective in minimizing enlarged face pores and improving skin hydration. CPM-HA20G demonstrated superior efficacy in terms of pore size reduction. Adverse events were generally mild and tolerable.

Indexed as

Cosmetic TechniquesDermal FillersHyaluronic AcidSkinSkin AgingAdultDouble-Blind MethodFaceFemaleGlycerolHumansInjections, IntradermalMaleMiddle AgedPatient SatisfactionPorosityDermal FillersGlycerolHyaluronic Aciddermal fillerfacial poresinjectablesrejuvenationskin booster

Identifiers

PMID40304039
PMCPMC12042064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.